CD19 Protein, Human (HEK293, His)
Based on 1 publication(s) in Google Scholar
The CD19 protein is a B cell antigen receptor coreceptor that enhances downstream signaling pathways, lowers the activation threshold, and helps B cells respond to antigens. It activates phosphatidylinositol 3-kinase and mobilizes intracellular Ca(2+). CD19 Protein, Human (HEK293, His) is the recombinant human-derived CD19 protein, expressed by HEK293 , with C-His labeled tag.
- Species: Human
- Source: HEK293
-
Storage:Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
.png&title=MedChemExpress Validation "Click to View Experimental Validation Results")
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Technical Parameters
-
Product Properties
- Documentation
- Help & FAQs
Biological Activity
The CD19 protein is a B cell antigen receptor coreceptor that enhances downstream signaling pathways, lowers the activation threshold, and helps B cells respond to antigens. It activates phosphatidylinositol 3-kinase and mobilizes intracellular Ca(2+). CD19 Protein, Human (HEK293, His) is the recombinant human-derived CD19 protein, expressed by HEK293 , with C-His labeled tag.
The CD19 Protein serves as a coreceptor for the B-cell antigen receptor complex (BCR) on B-lymphocytes, playing a pivotal role in decreasing the threshold for activation of downstream signaling pathways and facilitating B-cell responses to antigens. It activates signaling pathways leading to the activation of phosphatidylinositol 3-kinase and the mobilization of intracellular Ca(2+) stores. Although not required for early steps during B cell differentiation in the blood marrow, CD19 is essential for the normal differentiation of B-1 cells. Moreover, it is crucial for normal B cell differentiation and proliferation in response to antigen challenges, influencing serum immunoglobulin levels and the production of high-affinity antibodies in response to antigen challenge. CD19 forms complexes with CR2/CD21, CD81, and IFITM1/CD225 in the membrane of mature B-cells. It interacts directly with CD81, a crucial interaction for trafficking and compartmentalization of the CD19 receptor on the cell surface of activated B cells. Additionally, CD19 interacts with VAV, GRB2, SOS, PLCG2, LYN, and the regulatory p85 subunit of phosphatidylinositol 3-kinase when phosphorylated on specific tyrosine residues.
1.Immobilized human CD19-His at 2 μg/mL (100 μL/well) can bind Anti-CD19 Antibody and the EC50 is 5-100 ng/mL.
2.Immobilized Monoclonal Anti-Human CD19 Antibody (IgG1) at 2 μg/mL (100 μL/well) can bind Recombinant Human CD19 / Leu-12 Protein (ECD,His Tag) , the EC50 is 99-410 ng/mL.
3.Loaded Inebilizumab (HY-P99113) on AHC2 biosensor, can bind CD19 Protein, Human (HEK293, His) with an affinity constant of 1.240E-09 M as determined in BLI assay.
4.Loaded Duvortuxizumab (HY-P99868) on AHC2 biosensor, can bind CD19 Protein, Human (HEK293, His) with an affinity constant of <1.000E-11 M as determined in BLI assay.
5.Loaded Zeripatamig (HY-P990694) on AHC2 biosensor, can bind CD19 Protein, Human (HEK293, His) with an affinity constant of 2.935E-09 M as determined in BLI assay.
6.Immobilized Human CD19, His Tag at 2 μg/ml (100 μl/Well) on the plate. Dose response curve for Coltuximab, hFc Tag with the EC50 of 1-10 ng/mL determined by ELISA.
7.Immobilized Human CD19, His Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for FMC63, mFc Tag with the EC50 of 5-15 ng/mL determined by ELISA.
8.Loaded Inebilizumab (FUT8-KO, HY-P99113A) on ProA biosensor, can bind CD19 Protein, Human with an affinity constant of 2.984E-09 M as determined in BLI assay.
Publications (1)
-
Journal Impact Factor
-
Most Recent
Technical Parameters
-
Species Human
-
Source HEK293
-
Tag C-His
-
Accession
P15391-1 (P20-K291)
-
Molecular Construction
-
N-term
-
CD19 (P20-K291)
Accession # P15391-1 -
His
-
C-term
-
-
Protein Length
Extracellular Domain
-
Synonyms
CD19; CDNA FLJ60916, Highly Similar To B-Lymphocyte Antigen CD19; CD19 Molecule; CDNA FLJ54955, Highly Similar To B-Lymphocyte Antigen CD19; B-Lymphocyte Surface Antigen B4; CD19 Antigen, Isoform CRA_f; T-Cell Surface Antigen Leu-12; CD19 Antigen, Isoform
-
AA Sequence
PEEPLVVKVEEGDNAVLQCLKGTSDGPTQQLTWSRESPLKPFLKLSLGLPGLGIHMRPLAIWLFIFNVSQQMGGFYLCQPGPPSEKAWQPGWTVNVEGSGELFRWNVSDLGGLGCGLKNRSSEGPSSPSGKLMSPKLYVWAKDRPEIWEGEPPCLPPRDSLNQSLSQDLTMAPGSTLWLSCGVPPDSVSRGPLSWTHVHPKGPKSLLSLELKDDRPARDMWVMETGLLLPRATAQDAGKYYCHRGNLTMSFHLEITARPVLWHWLLRTGGWK
-
Predicted Molecular Mass
31.6 kDa
-
Molecular Weight
Approximately 47-60 kDa, based on SDS-PAGE under reducing conditions, due to the glycosylation.
-
Glycosylation
Yes
-
Purity
≥ 90%, as determined by reducing SDS-PAGE or Bis-Tris PAGE.
Product Properties
Lyophilized powder
Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
<1 EU/μg, determined by LAL method.
It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O.
Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
Room temperature in continental US; may vary elsewhere.
Documentation
-
Data Sheet (238 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz
